NEWS, PRESENTATIONS & PUBLICATIONS

News

IATERION, INC. ANNOUNCES PATRICK SUEL, M.SC., JOINS ITS BOARD OF DIRECTORS

Patrick Suel brings over 18 years of experience establishing and managing international Corporate VC funds.

IATERION, INC. ANNOUNCES DR. LORIN K JOHNSON Ph.D., JOINS ITS BOARD OF DIRECTORS AND THE SCIENTIFIC ADVISORY BOARD

Lorin K. Johnson, Ph.D. Founder, Managing Director and Chief Scientist of Glycyx PharmaVentures, Ltd. has joined the Board of Directors and the Scientific Advisory Board of Iaterion, Inc.

IATERION, INC. IS AWARDED A NATIONAL INSTITUTE OF HEALTH (NIH) GRANT FOR THE STUDY OF ITS NUCLEAR RECEPTOR COLIGAND PLATFORM

Iaterion, Inc. received an award from the National Institute of Aging (NIA) at the National Institute of Health (NIH) for the development of estrogen receptor reprogramming ligands for menopausal hormone therapy.

Presentations

Iaterion, Inc. Overview

MF5 for Menopausal Symptoms

Selective Publications

Tissue-Specific Regulation of Genes by Estrogen Receptors

Estrogen Receptor Binds to and Regulates Three Distinct Classes of Target Genes

Regulation of Specific Target Genes and Biological Responses by Estrogen Receptor Subtype Agonists

Estrogen Receptor Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest